Earnings Call Summary | AMBU A/S(AMBFF.US) Q2 2024 Earnings Conference
The following is a summary of the Ambu A/S (AMBFF) Q2 2024 Earnings Call Transcript:Financial Performance:Ambu A/S reported Q2 organic revenue growth of 15.5%, majorly backed by the endoscopy business
Ambu A/S: Reporting of Transactions Made by Persons Discharging Managerial Responsibilities
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S
Earnings Call Summary | AMBU A/S(AMBFF.US) Q1 2024 Earnings Conference
The following is a summary of the Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript:Financial Performance:Ambu reported a Q1 organic revenue growth of 14% with a total reported growth of 11%, due to d
Ambu A/S Reports Q1 Results
INTERIM REPORT FOR Q1 2023/24
Ambu A/S GAAP EPS of DKK0.06, Revenue of DKK1.19B
Ambu A/S (OTCMKTS:AMBBY) Shares Up 0.6%
Ambu A/S (OTCMKTS:AMBBY – Get Rating)'s stock price shot up 0.6% during trading on Wednesday . The company traded as high as $14.40 and last traded at $14.34. 1,200 shares were traded during mid-day
Ambu A/S (OTCMKTS:AMBBY) Rating Increased to Buy at DNB Markets
Ambu A/S (OTCMKTS:AMBBY – Get Rating) was upgraded by stock analysts at DNB Markets from a "hold" rating to a "buy" rating in a research note issued to investors on Thursday, The Fly reports.Separatel
Ambu A/S GAAP EPS of DKK0.09, Revenue of DKK1.13B
Ambu A/S (OTCMKTS:AMBBY) Short Interest Update
Ambu A/S (OTCMKTS:AMBBY – Get Rating) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 2,000 shares, an increase of 185
Ambu A/S (OTCMKTS:AMBBY) Shares Down 0.5%
Ambu A/S (OTCMKTS:AMBBY – Get Rating) shares fell 0.5% on Tuesday . The stock traded as low as $10.78 and last traded at $10.78. 328 shares traded hands during trading, a decline of 96% from the aver
Ambu A/S GAAP EPS of -DKK0.51, Revenue of DKK1.16B
Ambu A/S: Financial Calendar
This financial calendar lists the expected dates of publication of financial announcements and the Annual General Meeting for the financial year 2022/23. Please see attached PDF. CONTACTSThomas Frede
Ambu A/S (OTCMKTS:AMBBY) Trading Down 3.6%
Ambu A/S (OTCMKTS:AMBBY – Get Rating)'s share price was down 3.6% during mid-day trading on Tuesday . The stock traded as low as $8.08 and last traded at $8.08. Approximately 357 shares were traded
Ambu A/S (OTCMKTS:AMBBY) Shares Down 5%
Ambu A/S (OTCMKTS:AMBBY – Get Rating)'s stock price was down 5% during trading on Monday . The stock traded as low as $9.63 and last traded at $9.63. Approximately 500 shares traded hands during mid-
Ambu A/S Reports Q3 Results
Ambu A/S press release (OTCPK:AMBFF): Q3 Revenue of DKK1.13B (+16.1% Y/Y) FY 2021/22 FINANCIAL GUIDANCE Ambu maintains the financial guidance announced on 3 August 2022 at: Organic growth: no less th
Ambu A/S: Capital increase in connection with exercise of warrants issued
Ambu A/S issued 419,500 warrants in 2016. Each warrant entitled the holder to subscribe for one Class B share with a nominal value of DKK 0.50. 71 individuals participated in the 2016 scheme. For the
Ambu A/S CEO Juan Jose Gonzalez on Q1 2022 Results -- Earnings Call Transcript >AMBFF
From Seeking Alpha: Ambu A/S CEO Juan Jose Gonzalez on Q1 2022 Results -- Earnings Call Transcript
Ambu A/S GAAP EPS of DKK0.08, revenue of DKK1.03B
Ambu A/S press release (OTCPK:AMBFF): Q3 GAAP EPS of DKK0.08.Revenue of DKK1.03B (+2% Y/Y).
Ambu A/S: Interim report for Q1 2021/22
Ambu posted revenue for Q1 equal to the first quarter of last year, with organic growth of -1% and reported growth of 2%. Adjusted for last year's NHS safety-stock orders, the Visualization business g
No Data